Skip to main content

Table 1 Baseline characteristics of IgAN

From: The prognostic role of heart rate recovery after exercise and metabolic syndrome in IgA nephropathy

Clinical data

HRR ≥ 23

HRR < 23

P

Patients (n = 125)

60

65

 

Man/woman (n/%)

36/24 (60/40)

46/19 (71/29)

NS

Age (year)

51.4 ± 12.5

54.7 ± 13.0

NS

Average systolic RR (Hgmm)

120.1 ± 0.6

126.7 ± 0.8

0.002

Average diastolic RR (Hgmm)

73 ± 9.6

75.7 ± 9.5

NS

24 h pulse pressure (Hgmm)

47.40 ± 7.96

51.10 ± 8.85

0.012

Diurnal index systolic (%)

10.92 ± 5.08

8.36 ± 7.72

0.020

Metabolic parameters

 Hypertension (n, %)

41 (68)

53 (81)

NS

 BMI (kg/m2)

25.17 ± 3.8

27.7 ± 4.8

0.001

 Dyslipidaemia (n, %)

24 (40)

34 (52)

NS

 Carbohydrate metabolic disorder (n, %)

9 (15)

21 (32)

NS

 eGFR (ml/min)

94.6 ± 29.3

78.9 ± 37.9

0.005

 Duration of kidney disease (year)

10.2 ± 9.7

8.8 ± 9.1

NS

 Smoking (n, %)

7 (12)

11(17)

NS

 Metabolic syndrome (n, %)

13 (22)

21 (32)

NS

Therapy

 ACEI/ARB (n, %)

46 (77)

60 (92)

NS

 BB (n, %)

12 (20)

19 (29)

NS

 Statin (n, %)

16 (27)

22 (34)

NS

 CCB (n, %)

9 (15)

19 (29)

NS

Ergometry

 Average heart rate (beat/min)

72.1 ± 8.8

76.0 ± 10.9

0.016

 Stress test time (s)

608 ± 178.3

550 ± 186.5

0.039

 HRR (bpm)

31.2 ± 7.4

15.6 ± 5.1

< 0.001

 CAD (Positive stress test)

5 (8)

12 (18)

NS

Echocardiographic parameters

 LV EF (%)

62.4 ± 6.9

63.2 ± 5.9

NS

 LVMI

103.53 ± 15.95

109.21 ± 21.25

NS

 LVM (g)

196.8 ± 41.5

212.1 ± 38.5

NS

 LVEDD (cm)

6.05 ± 6.29

5.57 ± 5.13

NS

 DD (n/%)

7 (11)

17 (26)

< 0.001

 E/A

1.18 ± 0.32

0.93 ± 0.30

< 0.001

Laboratory results

 Hb (g/dl)

13.9 ± 1.6

13.6 ± 1.7

NS

 MAU (mg/day)

406 ± 578.6

504 ± 642.3

NS

 HUS (umol/l)

303 ± 97.4

342 ± 84.9

0.009

 Total cholesterol (mmol/l)

5.01 ± 1.28

4.93 ± 1.06

NS

 HDL cholesterol (mmol/l)

1.35 ± 0.57

1.20 ± 0.31

0.029

 TG (mmol/l)

1.49 ± 0.88

1.93 ± 1.21

0.012

  1. HRR heat rate recovery, RR blood pressure, BMI body mass index, eGFR estimated glomerular filtration rate, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, BB beta blocker, CCB calcium channel blocker, CAD coronary artery disease, LV EF left ventricle ejection fraction, LVMI left ventricle mass index, LVM left ventricular mass, LVEDD left ventricular end-diastolic diameter, DD diastolic dysfunction, Hb hemoglobin, MAU microalbuminuria, HUS uric acid, HDL cholesterol: high-density lipoprotein cholesterol, TG triglyceride